Kristen is a National Library of Medicine Predoctoral Fellow in Bioinformatics and Computational Biology and also a student in the Medical Scientist Training Program (MD/PhD) at Oregon Health &Science University School of Medicine. After completing her undergraduate degree at the University of California, Berkeley, Kristen worked with Ronald Krauss and Marisa Medina at Children's Hospital Oakland Research Institute investigating inter-individual variation in statin response to identify novel drug targets for treating cardiovascular disease. Her current interests include the epigenetics of complex traits, developmental genomics, and biochemical and molecular nutrition.
Oregon Health &Science University
Medical Scientist Training Program
MD, Expected June 2021
PhD in Bioinformatics and Computational Biology, Expected June 2019
Advisors: Shannon McWeeney, PhD and Eilis Boudreau, MD, PhD
University of California, Berkeley
Bachelor of Arts, Molecular &Cell Biology, English Minor, May 2010
Honors Thesis: "Increased stearoyl-CoA desaturase activity contributes to atherogenic dyslipidemia on a diet high in beef and saturated fat"
Advisors: Ronald Krauss, MD and Lara Mangravite, PhD
1. Theusch E, Kim K, Stevens K, Smith JD, Chen YI, Rotter JI, Nickerson DA, and Medina MW (2016) Statin-induced expression change of INSIG1 in lymphoblastoid cell lines correlates with plasma triglyceride statin response in a sex-specific manner. The Pharmacogenomics Journal. doi: 10.1038/tpj.2016.12.
2. Medina MW, Bauzon F, Naidoo D, Theusch E, Stevens K, Schilde J, Schubert C, Mangravite LM, Rudel LL, Temel RE, Runz H, and Krauss RM (2014) Transmembrane Protein 55B is a novel regulator of cellular cholesterol metabolism. Arteriosclerosis, Thrombosis, and Vascular Biology. doi: 10.1161/ATVBAHA.113.302806.
3. Medina MW, Theusch E, Naidoo D, Bauzon F, Stevens K, Mangravite LM, Kuang YL, and Krauss RM (2012) RHOA is a modulator of the cholesterol-lowering effects of statin. PLOS Genetics 8(11): e1003058. doi: 10.1371/journal.pgen.1003058